Umar Mehraj
Srinagar, JK, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Editorial: p53 in cancer therapy: the impact of mutations on the genome guardian.
Journal: Frontiers in immunology
Published: March 25, 2026
Adapalene inhibits the activity of CD44, a cancer stem cell biomarker in Triple negative breast cancer.
Journal: Molecular biology reports
Published: March 23, 2026
NUAK2 is a therapeutically tractable regulator of RNA splicing and tumor progression in neuroendocrine prostate cancer.
Journal: bioRxiv : the preprint server for biology
Published: November 26, 2025
Chloroquine sensitises hypoxic colorectal cancer cells to ROS-mediated cell death via structural disruption of pyruvate dehydrogenase kinase 1.
Journal: Free radical biology & medicine
Published: September 28, 2024
Clinicopathological Significance and Expression Pattern of Bcl2 in Breast Cancer: A Comprehensive in silico and in vitro Study.
Journal: Saudi journal of biological sciences
Published: November 13, 2023
Synthesis and Biological Evaluation of Novel Uracil Derivatives as Thymidylate Synthase Inhibitors.
Journal: Applied biochemistry and biotechnology
Published: January 10, 2023
Adapalene inhibits the growth of triple-negative breast cancer cells by S-phase arrest and potentiates the antitumor efficacy of GDC-0941.
Journal: Frontiers in pharmacology
Published: May 31, 2022
Expression patterns and therapeutic implications of CDK4 across multiple carcinomas: a molecular docking and MD simulation study.
Journal: Medical oncology (Northwood, London, England)
Published: May 17, 2022
Adapalene and Doxorubicin Synergistically Promote Apoptosis of TNBC Cells by Hyperactivation of the ERK1/2 Pathway Through ROS Induction.
Journal: Frontiers in oncology
Published: May 06, 2022
Expression pattern and prognostic significance of CDKs in breast cancer: An integrated bioinformatic study.
Journal: Cancer biomarkers : section A of Disease markers
Published: May 02, 2022
Targeting cyclin-dependent kinase 1 (CDK1) in cancer: molecular docking and dynamic simulations of potential CDK1 inhibitors.
Journal: Medical oncology (Northwood, London, England)
Published: April 13, 2022
Cyclin-dependent kinases in breast cancer: expression pattern and therapeutic implications.
Journal: Medical oncology (Northwood, London, England)
Published: March 02, 2022
Last Updated: 09/26/2026